Tech Company Financing Transactions

Casma Therapeutics Funding Round

On 11/15/2022, Casma Therapeutics announced $46 million in Series C funding from Amgen Ventures, Astellas Venture Capital and Eisai.

Transaction Overview

Company Name
Casma Therapeutics
Announced On
11/15/2022
Transaction Type
Venture Equity
Amount
$46,000,000
Round
Series C
Investors

Amgen Ventures (Lead Investor)

Astellas Venture Capital (Lead Investor)

Eisai (Lead Investor)

Euclidean Capital (Lead Investor)

Mirae Asset Capital (Lead Investor)

Ono Venture Investment (Lead Investor)

Eventide Asset Management (Finny Kuruvilla)

Schroders Capital

The Column Group (Millie Ray)

Third Rock Ventures (Cary Pfeffer)

Proceeds Purpose
The company intends to use the funds to advance its lead program for MYD88 mutant lymphoma through preclinical and into IND enabling studies.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Technology Sq. 201
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
www.casmatx.com
Email Address
[email protected]
Overview
New discoveries are revealing the fundamental role of autophagy and lysosomal flux in maintaining cellular health. Furthermore, it is now appreciated that inadequate or aberrant autophagy contributes to a wide range of diseases. We are focused on boosting autophagy -- pioneering novel therapeutic strategies to address unmet medical needs.
Profile
Casma Therapeutics LinkedIn Company Profile
Social Media
Casma Therapeutics Company Twitter Account
Company News
Casma Therapeutics News
Facebook
Casma Therapeutics on Facebook
YouTube
Casma Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Keith Dionne
  Keith Dionne LinkedIn Profile  Keith Dionne Twitter Account  Keith Dionne News  Keith Dionne on Facebook
Chief Operating Officer
Frank Gentile
  Frank Gentile LinkedIn Profile  Frank Gentile Twitter Account  Frank Gentile News  Frank Gentile on Facebook
Chief Scientific Officer
Leon Murphy
  Leon Murphy LinkedIn Profile  Leon Murphy Twitter Account  Leon Murphy News  Leon Murphy on Facebook
Vice President
Daniel Ory
  Daniel Ory LinkedIn Profile  Daniel Ory Twitter Account  Daniel Ory News  Daniel Ory on Facebook
Vice President
Jeffrey Saunders
  Jeffrey Saunders LinkedIn Profile  Jeffrey Saunders Twitter Account  Jeffrey Saunders News  Jeffrey Saunders on Facebook
VP - Finance
Colleen DeSimone
  Colleen DeSimone LinkedIn Profile  Colleen DeSimone Twitter Account  Colleen DeSimone News  Colleen DeSimone on Facebook
VP - Human Resources
Caren Block
  Caren Block LinkedIn Profile  Caren Block Twitter Account  Caren Block News  Caren Block on Facebook

 

 

Browse more venture capital transactions:

Prev: 11/15/2022: BasiGo venture capital transaction
Next: 11/15/2022: Yahaha Studios venture capital transaction

 

Share this article

 

News on VC Transactions

We report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.